134 related articles for article (PubMed ID: 20211271)
1. Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease.
Baudrexel S; Nürnberger L; Rüb U; Seifried C; Klein JC; Deller T; Steinmetz H; Deichmann R; Hilker R
Neuroimage; 2010 Jun; 51(2):512-20. PubMed ID: 20211271
[TBL] [Abstract][Full Text] [Related]
2. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
[TBL] [Abstract][Full Text] [Related]
3. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.
Martin WR; Wieler M; Gee M
Neurology; 2008 Apr; 70(16 Pt 2):1411-7. PubMed ID: 18172063
[TBL] [Abstract][Full Text] [Related]
4. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.
Michaeli S; Oz G; Sorce DJ; Garwood M; Ugurbil K; Majestic S; Tuite P
Mov Disord; 2007 Feb; 22(3):334-40. PubMed ID: 17149719
[TBL] [Abstract][Full Text] [Related]
5. Multispectral quantitative magnetic resonance imaging of brain iron stores: a theoretical perspective.
Jara H; Sakai O; Mankal P; Irving RP; Norbash AM
Top Magn Reson Imaging; 2006 Feb; 17(1):19-30. PubMed ID: 17179894
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
7. Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging.
Cho ZH; Oh SH; Kim JM; Park SY; Kwon DH; Jeong HJ; Kim YB; Chi JG; Park CW; Huston J; Lee KH; Jeon BS
Mov Disord; 2011 Mar; 26(4):713-8. PubMed ID: 21506148
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
10. Motor-related circuit dysfunction in MSA-P: Usefulness of combined whole-brain imaging analysis.
Tir M; Delmaire C; le Thuc V; Duhamel A; Destée A; Pruvo JP; Defebvre L
Mov Disord; 2009 Apr; 24(6):863-70. PubMed ID: 19194988
[TBL] [Abstract][Full Text] [Related]
11. White matter abnormalities in autism detected through transverse relaxation time imaging.
Hendry J; DeVito T; Gelman N; Densmore M; Rajakumar N; Pavlosky W; Williamson PC; Thompson PM; Drost DJ; Nicolson R
Neuroimage; 2006 Feb; 29(4):1049-57. PubMed ID: 16214373
[TBL] [Abstract][Full Text] [Related]
12. [Magnetic resonance imaging in Parkinson's disease--the evaluation of the width of pars compacta on T2 weighted image].
Moriwaka F; Tashiro K; Itoh K; Hamada T; Miyasaka K
Rinsho Shinkeigaku; 1992 Jan; 32(1):8-12. PubMed ID: 1628441
[TBL] [Abstract][Full Text] [Related]
13. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
14. When does Parkinson's disease begin?
Gaig C; Tolosa E
Mov Disord; 2009; 24 Suppl 2():S656-64. PubMed ID: 19877243
[TBL] [Abstract][Full Text] [Related]
15. Quantitative estimation of regional brain iron with magnetic resonance imaging.
Martin WR
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S215-8. PubMed ID: 20082994
[TBL] [Abstract][Full Text] [Related]
16. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
[TBL] [Abstract][Full Text] [Related]
17. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.
Meppelink AM; de Jong BM; Renken R; Leenders KL; Cornelissen FW; van Laar T
Brain; 2009 Nov; 132(Pt 11):2980-93. PubMed ID: 19755518
[TBL] [Abstract][Full Text] [Related]
18. Clustering of atlas-defined cortical regions based on relaxation times and proton density.
Aubert-Broche B; Grova C; Pike GB; Collins DL
Neuroimage; 2009 Aug; 47(2):523-32. PubMed ID: 19426811
[TBL] [Abstract][Full Text] [Related]
19. Low-frequency MEG activity and MRI evaluation in Parkinson's disease.
Kotini A; Anninos P; Adamopoulos A; Prassopoulos P
Brain Topogr; 2005; 18(1):59-63. PubMed ID: 16193267
[TBL] [Abstract][Full Text] [Related]
20. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
Fisher E; Chang A; Fox RJ; Tkach JA; Svarovsky T; Nakamura K; Rudick RA; Trapp BD
Ann Neurol; 2007 Sep; 62(3):219-28. PubMed ID: 17427920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
